CorMedix Inc. to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
May 16 2019 - 8:45AM
CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company
focused on developing and commercializing therapeutic products for
the prevention and treatment of infectious and inflammatory
disease, today announced that management will present a corporate
overview at the 20th Annual B. Riley FBR Institutional Investor
Conference, being held May 22-23 at the Beverly Hilton Hotel in
Beverly Hills, California.
20th Annual B. Riley FBR Institutional Investor
Conference
Date:
|
Wednesday,
May 22nd |
Time: |
2:00pm Eastern/11:00am Pacific Time |
Webcast: |
http://www.wsw.com/webcast/brileyfbr3/crmd/ |
About CorMedixCorMedix Inc. is
a biopharmaceutical company focused on developing and
commercializing therapeutic products for the prevention and
treatment of infectious and inflammatory diseases. The Company is
focused on developing its lead product Neutrolin®, a novel,
non-antibiotic antimicrobial solution designed to prevent costly
and dangerous bloodstream infections associated with the use of
central venous catheters, currently in Phase 3 development for
patients undergoing chronic hemodialysis. Such infections have
significant treatment costs and lead to increased morbidity and
mortality. Neutrolin has FDA Fast Track status and is designated as
a Qualified Infectious Disease Product, which provide the potential
for priority review of a marketing application by FDA and allow for
a total of ten years of market exclusivity in the event of U.S.
approval. Neutrolin is already marketed as a CE Marked product in
Europe and other territories. In parallel, CorMedix is leveraging
its taurolidine technology to develop a pipeline of antimicrobial
medical devices, with active programs in surgical sutures and
meshes, and topical hydrogels. The company is also working
with top-tier researchers to develop taurolidine-based therapies
for rare pediatric cancers. For more information, visit:
www.cormedix.com.
Investor Contact:Dan FerryManaging
DirectorLifeSci Advisors617-535-7746
CorMedix (AMEX:CRMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
CorMedix (AMEX:CRMD)
Historical Stock Chart
From Sep 2023 to Sep 2024